Welcome to Labeled Immunoassays and Clinical Medicine website!

99Tcm-DX Lymphoscintigraphy in Patients with Lymph Node Malignancy Present with Lower Limbs Lymphedema as Initial Symptom

  • 文 哲1 ,
  • 项 睿2,刘 勇1,童冠圣1 ,
  • 沈文彬3,张 丽1,李 征1
Expand
  • Department of Nuclear Medicine, Beijing Shijitan Hospital,Capital Medical University, Beijing, 100038, China

Online published: 2013-11-01

Abstract

Objective To Investigate the diagnostic value of 99Tcm-DX lymphoscintigraphy in lower limbs lymphedema as the initial symptom of lymphnode malignant tumor. Methods Twenty-one lymph node malignant tumor patients initially diagnosed as lymphedema were studied retrospectively. After the injection of 99Tcm-DX into the first interdigital space of both feet, lymphoscintigraphy was performed at 10 min, 1, 3 and 6 hour intermittently. Results Lymphoscintigrams were analyzed for visualization of lymphatics and lymph nodes, dermal backflow of radiotracers in all bodies. The main characteristics included the lymphatic blockage,lateral branch lymphatic,dermal backflow,non-imaging lymph nodes. Conclusion As a noninvasive, accurate and effective imaging modality, lymphangioscintigraphy may be the first choice for evaluating lower limbs lymphedema as the initial symptom of lymphnode malignant tumor.

Cite this article

文 哲1 , 项 睿2,刘 勇1,童冠圣1 , 沈文彬3,张 丽1,李 征1 . 99Tcm-DX Lymphoscintigraphy in Patients with Lymph Node Malignancy Present with Lower Limbs Lymphedema as Initial Symptom[J]. Labeled Immunoassays and Clinical Medicine, 2013 , 20(5) : 311 -314 . DOI: 10.11748/bjmy.issn.1006-1703.2013.05.011

Outlines

/